Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Long-Term-Investments" stands at 2.81 Billion United States Dollars as of 09/30/2025, the lowest value since 12/31/2023.
As of the end of Eli Lilly and Company's third quarter, the item "Long Term Investments" stands at 2.81 Billion USD. This represents a decrease of -12.44 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -12.25 percent compared to the value the year prior.
The 1 year change in percent is -12.25.
The 3 year change in percent is 9.08.
The 5 year change in percent is 13.41.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Long Term Investments | 486,508,953,600.00 |
![]() | AbbVie Inc - Long Term Investments | 399,570,305,024.00 |
![]() | Roche Holding AG - Long Term Investments | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Long Term Investments | 280,205,508,085.11 |
![]() | Novartis AG - Long Term Investments | 255,096,620,580.91 |